Your browser doesn't support javascript.
loading
[Improvement of LDL-C target value achievement through cardiac rehabilitation in patients with acute coronary syndrome: PATIENT-CARE registry]. / Verbesserte LDL-Cholesterin-Zielwerterreichung bei Patienten mit akutem Koronarsyndrom in der kardiologischen Rehabilitation: PATIENT-CARE-Register.
Schwaab, Bernhard; Zeymer, Uwe; Jannowitz, Christina; Pittrow, David; Gitt, Anselm.
Afiliação
  • Schwaab B; Curschmann Klinik, Rehabilitationskrankenhaus für Kardiologie, Angiologie und Diabetologie, Akademisches Lehrkrankenhaus der Universität zu Lübeck, Saunaring 6, 23669, Timmendorfer Strand, Deutschland. prof.schwaab@drguth.de.
  • Zeymer U; Medizinische Klinik B, Herzzentrum Ludwigshafen und Institut für Klinische Pharmakologie, Technische Universität Dresden, Dresden, Deutschland.
  • Jannowitz C; Medizinische Abteilung, MSD Sharp & Dohme GmbH, Haar, Deutschland.
  • Pittrow D; Institut für Klinische Pharmakologie, Technische Universität Dresden, Dresden, Deutschland.
  • Gitt A; Medizinische Klinik B, Herzzentrum Ludwigshafen und Stiftung IHF - Institut für Herzinfarktforschung, Ludwigshafen/Rhein, Deutschland.
MMW Fortschr Med ; 161(Suppl 5): 21-24, 2019 Jul.
Article em De | MEDLINE | ID: mdl-31313267
ABSTRACT

BACKGROUND:

For patients undergoing acute coronary syndrome, participation in cardiac rehabilitation includes, in addition to lifestyle modification, optimal adjustment to secondary preventive medication. As a result, follow-up events can be prevented very effectively.

METHOD:

The PATIENT-CARE registry study examined the treatment of patients during rehabilitation. Of particular interest was whether LDL cholesterol (LDL-C) targets were met.

RESULTS:

The rate of treated patients increased in almost all classes of medication. At discharge, 96.7% of patients received statins, 98.5% antithrombotics and 22.3% antidiabetics. LDL-C was significantly reduced during rehabilitation - on average by 21.3 mg/dl (0.55 mmol/l). 41.9% of the patients achieved the LDL-C target value.

CONCLUSION:

The results show that the optimization of secondary drug prevention in the outpatient sector must be continued unconditionally and consistently.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Síndrome Coronariana Aguda / Fibrinolíticos / Reabilitação Cardíaca / Hipoglicemiantes / LDL-Colesterol Limite: Humans Idioma: De Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Hidroximetilglutaril-CoA Redutases / Síndrome Coronariana Aguda / Fibrinolíticos / Reabilitação Cardíaca / Hipoglicemiantes / LDL-Colesterol Limite: Humans Idioma: De Ano de publicação: 2019 Tipo de documento: Article